Allarity Therapeutics, Inc. (ALLR) Tops Q1 EPS by 763c

Allarity Therapeutics, Inc. (NASDAQ: ALLR) reported Q1 EPS of ($0.25), $7.63 better than the analyst estimate of ($7.88).

For earnings history and earnings-related data on Allarity Therapeutics, Inc. (ALLR) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Trump: 40-60% of chip manufacturing will be in the U.S. - CNBC Interview
• JPMorgan Upgrades Nanya Technology Corp (2408:TT) to Overweight